Use of convalescent plasma in COVID-19 patients in China.
作者信息
Zhu M, Hu K, Zhu Z
机构信息
Department of Clinical Laboratory, The Affiliated Chaohu Hospital of Anhui Medical University. No. 64, ChaoHu North Road ChaoHu City, Anhui Province, 238000 China.
出版信息
Transfus Clin Biol. 2020 Aug;27(3):168-169. doi: 10.1016/j.tracli.2020.05.001. Epub 2020 May 16.
Abstract
摘要
相似文献
1
Use of convalescent plasma in COVID-19 patients in China.中国新冠病毒肺炎康复者恢复期血浆在新冠肺炎患者中的应用。
Transfus Clin Biol. 2020 Aug;27(3):168-169. doi: 10.1016/j.tracli.2020.05.001. Epub 2020 May 16.
2
Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.来自新冠病毒感染康复者的捐赠者血浆——优先事项问题
Transfus Clin Biol. 2020 Aug;27(3):167-168. doi: 10.1016/j.tracli.2020.05.002. Epub 2020 Jun 12.
3
The convalescent sera option for containing COVID-19.使用康复期血清来控制新型冠状病毒肺炎。
J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.
4
INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY.新冠康复期血浆输注与危重症COVID-19患者临床改善相关：一项初步研究。
Rev Invest Clin. 2020;72(3):159-164. doi: 10.24875/RIC.20000237.
5
Audio Interview: Capitalizing on Immune Responses to Covid-19.音频访谈：利用对新冠病毒的免疫反应
N Engl J Med. 2020 May 21;382(21):e93. doi: 10.1056/NEJMe2019020.
6
Convalescent Plasma: Promise for COVID-19 Pandemic.恢复期血浆：对新冠疫情的希望
J Coll Physicians Surg Pak. 2020 Jun;30(6):88. doi: 10.29271/jcpsp.2020.Supp1.S88.
7
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.关于制备用于治疗COVID-19患者的免疫血浆的立场文件。
Transfus Apher Sci. 2020 Aug;59(4):102817. doi: 10.1016/j.transci.2020.102817. Epub 2020 May 21.
8
Management of COVID-19 Virus Infection by Convalescent Plasma.恢复期血浆治疗新型冠状病毒肺炎病毒感染
Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):3-6. doi: 10.18502/ijaai.v19i(s1.r1).2847.
9
The resurgence of convalescent plasma therapy.恢复期血浆疗法的复兴。
Lancet Haematol. 2020 May;7(5):e353. doi: 10.1016/S2352-3026(20)30117-4.
10
Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19.冠状病毒药物：使用康复患者的血浆治疗新冠肺炎。
Int J Risk Saf Med. 2020;31(2):47-51. doi: 10.3233/JRS-201017.
引用本文的文献
1
Retrospective Analysis of Coronavirus SARS-CoV-2 Antibody Levels in COVID-19 Convalescent Plasma From Blood Donors.新冠康复献血者血浆中新型冠状病毒SARS-CoV-2抗体水平的回顾性分析
Can J Infect Dis Med Microbiol. 2024 Dec 5;2024:4366502. doi: 10.1155/cjid/4366502. eCollection 2024.
2
Perplexing issues for convalescent immune plasma therapy in COVID-19.新冠康复期免疫血浆疗法面临的棘手问题。
North Clin Istanb. 2021 Nov 15;8(6):634-643. doi: 10.14744/nci.2021.73604. eCollection 2021.
3
Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.康复期新冠病毒肺炎血浆治疗：回归基础与伦理，以及后续步骤
Transfus Clin Biol. 2021 Aug;28(3):225-227. doi: 10.1016/j.tracli.2021.07.005.
4
Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的基础与进阶疗法及疫苗研发
Pathogens. 2021 May 21;10(6):636. doi: 10.3390/pathogens10060636.
5
What has changed after the COVID-19 pandemic in the publication process? A look-back to "Transfusion clinique et biologique".新冠疫情之后，出版流程发生了哪些变化？回顾《临床与生物学输血》。
Transfus Clin Biol. 2021 May;28(2):129-131. doi: 10.1016/j.tracli.2021.04.001.
6
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.
7
Review of pharmacologic and immunologic agents in the management of COVID-19.新型冠状病毒肺炎治疗中药物及免疫制剂的综述
Biosaf Health. 2021 Jun;3(3):148-155. doi: 10.1016/j.bsheal.2021.01.001. Epub 2021 Jan 9.
8
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.新冠康复者血浆或高效免疫球蛋白用于新冠患者：一项实时系统评价
Cochrane Database Syst Rev. 2020 Jul 10;7(7):CD013600. doi: 10.1002/14651858.CD013600.pub2.
Zotero 插件